Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Shareholders Equity (Quarterly) : 94.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.50M |
| March 31, 2026 | 50.28M |
| December 31, 2025 | 57.96M |
| September 30, 2025 | 63.03M |
| June 30, 2025 | 45.96M |
| March 31, 2025 | 54.07M |
| December 31, 2024 | 61.65M |
| September 30, 2024 | 70.82M |
| June 30, 2024 | 80.02M |
| March 31, 2024 | 89.16M |
| December 31, 2023 | 106.18M |
| September 30, 2023 | 123.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 139.26M |
| March 31, 2023 | 155.20M |
| December 31, 2022 | 169.32M |
| September 30, 2022 | 131.94M |
| June 30, 2022 | 147.85M |
| March 31, 2022 | 163.04M |
| December 31, 2021 | 175.60M |
| September 30, 2021 | 186.49M |
| June 30, 2021 | 112.66M |
| March 31, 2021 | 123.25M |
| December 31, 2020 | 136.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.06M |
| Total Liabilities (Quarterly) | 3.567M |
| Current Ratio | 27.26 |
| Net Debt Paydown Yield | 0.03% |